Ralph Weichselbaum, MD, the Daniel K. Ludwig Distinguished Service Professor of Radiation and Cellular Oncology at the University of Chicago, is the guest of honor on today’s show focusing on radiation oncology as a discipline: the changes that have occurred over the years, the state of the field today, and how the field projects over the next few years. Dr. Weichselbaum highlights the malignancies that are poised for improvements in radiation outcomes in the coming years, how little attention is paid to radiation oncology in medical school, the potential of proton therapy and the need for prospective randomized controlled trials in some diseases, and a Lancet Oncology paper he reacted strongly to on Twitter.
N/A
Dr. Joe Mikhael, Chief Medical Officer of the International Myeloma Foundation (IMF) and Professor at TGen, takes us beyond his medical career to explore the personal experiences that have shaped his journey in oncology. Dr. Mikhael discusses the IMF’s targeted strategies for reducing health disparities among diverse ethnic and racial groups affected by myeloma, shedding
Tom Beer, Chief Medical Officer of the Multi-Cancer Early Detection (MCED) program at Exact Sciences, delves into the groundbreaking science behind MCED tests, which use advanced biomarkers for early detection of multiple cancer types. On this Healthcare Unfiltered episode, he explains who may be eligible for these tests, how to interpret results to avoid unnecessary
In this special episode, I give up the microphone to guest host Kelly Ryerson, who takes over the show asking questions about my new book “The Cancer Journey.”
